Aims: The receptor for B-cell-activating factor belonging to the tumour necrosis factor family (BAFF-R) and transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) have been established as binding molecules to BAFF. The aim of this study was to determine the pathological diagnostic roles and clinical significance of these BAFF-binding receptors in B-cell neoplasms.

Methods And Results: Expression of BAFF-R and TACI was examined immunohistochemically in reactive lymphoid tissues and B-cell lymphomas including diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), mantle cell lymphoma (MCL), marginal zone B-cell lymphoma (MZBCL) and plasma cell myeloma (PCM). In reactive tissues BAFF-R was expressed exclusively in the cells of the mantle zone and within the germinal centres (GCs), whereas TACI appeared positive in the scattered cells in extrafollicular areas. There were variable patterns of expression of BAFF-R and TACI amongst the different types of B-cell lymphomas (MCL and FL: BAFF-R+TACI-; PCM: BAFF-R-TACI+; DLBCL and MZBCL: variable expression). Reverse transcriptase-polymerase chain reaction studies supported these results. The overall survival of the BAFF-R+ DLBCL group was significantly better than that of the BAFF-R- group.

Conclusions: These results indicate that the assessment of expression of BAFF-binding receptors aids subclassification and prognostication of DLBCL.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2008.03203.xDOI Listing

Publication Analysis

Top Keywords

expression baff-r
12
baff-r taci
12
b-cell lymphomas
12
reactive lymphoid
8
lymphoid tissues
8
tissues b-cell
8
baff-binding receptors
8
b-cell lymphoma
8
b-cell
6
expression
5

Similar Publications

While B cell development in the birds' primary B cell organ, the bursa Fabricius, is relatively well understood, very little is known about post bursal B cell differentiation into plasma and memory cells though these cells are essential for a protecting antibody response and so far, no specific markers for these cells were available. Since immunoglobulin class switch is one part of the B cell differentiation process, our objective was to conduct a first detailed investigation of class-switched chicken B cells. As only very few IgY and IgA expressing cells were detected in lymphoid organs of young chickens, we used CD40L and IL-10 to establish a prolonged culture system, which induces B cell proliferation, class switch to IgY and IgA and enhanced antibody secretion.

View Article and Find Full Text PDF

The immune cells causative role in lung cancer: Mendelian randomization study.

Discov Oncol

November 2024

Department of Respiratory and Critical Care Medicine, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou, 412000, Hunan, China.

Backgrounds: Lung cancer (LC) is the leading cause of cancer-related deaths in China, with its incidence and mortality rates rising annually. Various studies have demonstrated disparities in immune cell counts and profiles between LC patients and healthy individuals. However, the existence of a causal link remains largely uncertain.

View Article and Find Full Text PDF

NF-ΚB Activation as a Key Driver in Chronic Lymphocytic Leukemia Evolution to Richter's Syndrome: Unraveling the Influence of Immune Microenvironment Dynamics.

Genes (Basel)

November 2024

Stem Cell Laboratory, Specialized Laboratories Division, Instituto Nacional de Câncer (INCA), Rio de Janeiro 20230-130, RJ, Brazil.

: Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in Western countries and it can progress to Richter's syndrome (RS), a more aggressive condition. The NF-κB pathway is pivotal in CLL pathogenesis, driven mainly by B-cell receptor (BCR) signaling. However, recent evidence indicates that BCR signaling is reduced in RS, raising questions about whether and how NF-κB activity is maintained in RS.

View Article and Find Full Text PDF
Article Synopsis
  • - This study aims to explore the relationship between immune cells and sepsis by employing a method called Mendelian randomization (MR) to identify specific immune cell types that may influence the onset of sepsis.
  • - The researchers utilized genetic data (specifically SNPs) for immune cell phenotypes from the GWAS catalog and sepsis data from the UK Biobank to analyze the associations and ensure reliability through various statistical tests.
  • - Findings revealed that certain immune cell phenotypes, particularly CD16 on CD14CD16 monocytes, showed causal links with sepsis, and after correcting for multiple comparisons, 42 immune cell types were identified as potentially associated with different outcomes in sepsis cases, such as 28-day mortality.
View Article and Find Full Text PDF
Article Synopsis
  • There is a significant challenge with treating relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) using existing CAR T-cell therapies, particularly as there are no approved options for CLL patients.
  • This study focuses on a new CAR design targeting the B-cell activating factor receptor (BAFF-R), which is crucial for the survival of B-cells and commonly found on CLL tumors.
  • The research showed that BAFF-R CAR T cells are effective in killing CLL cells and can also target resistant CD19-knockout CLL cells, suggesting that this therapy could provide a much-needed treatment option for CLL patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!